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Specialty Update

What’s New in Spine Surgery
By Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Alexander R. Vaccaro, MD, and Jeffrey C. Wang, MD

What’s New in the Treatment
of the Cervical Spine
The results of randomized controlled trials of several cervical
arthroplasty devices are becoming available and are the focus
of much attention. At the same time, secondary outcomes are
being analyzed that may address socioeconomic concerns
about the costs and observable benefits of arthroplasty. Since
the introduction of a validated outcome tool to measure swallowing dysfunction, researchers have more critically analyzed
postoperative dysphagia. With the continued expansion of the
use of cervical laminoplasty, methods to reduce complications continue to be explored.
Disc Arthroplasty
Disc arthroplasty is currently undergoing rigorous clinical
testing, and the outcomes of this procedure are being compared with those of fusion in randomized controlled trials.
The inclusion criteria are single level radiculopathy or myelopathy, failure of nonoperative management, adult age, and
the absence of significant instability or severe spondylosis or
facet disease. Full reports on these trials are not yet available.
However, pooled results from several investigation sites have
been presented for three different prostheses. All studies have
shown significant improvements in outcome measures for
both fusion and experimental groups. With arthroplasty, the
mean range of motion has increased by 1° to 2° and the rates
of complications related to the procedure have been low, with
no differences compared with controls. Two studies evaluating
titanium polyurethane and stainless steel metal-on-metal
prostheses demonstrated that the pooled site outcomes were
significantly better for the arthroplasty group than for the fusion group with regard to pain, disability, and overall success.
Specialty Update has been developed in collaboration with the Council of
Musculoskeletal Specialty Societies (COMSS) of the American Academy of
Orthopaedic Surgeons.

Six-year outcomes from Europe are encouraging, with patients maintaining clinical improvement and motion. Adjacent-segment disease appears to progress in patients with
preexisting disease but not in its absence.
From outside the United States, there have been case
reports of complications, including the late development of
central stenosis secondary to osteophyte formation, fracture
of a vertebral body during insertion, spontaneous fusion, expulsion of the device, and kyphotic angulation. Despite these
cases, the results of disc arthroplasty are encouraging, but
longer follow-up is needed.
Early return to function is a hypothetical benefit of
arthroplasty. In general, arthroplasty does not require immobilization and patients are allowed to rapidly return to full
function. The median time to return to work is significantly
better following arthroplasty than it is following fusion. This
effect is even greater in patients receiving Workers’ Compensation. From a socioeconomic perspective, this may mitigate
the additional cost of the implant and the additional surgical
time.
Complications
Wang et al. reported on the complications and mortality associated with surgical treatment in patients with degenerative
cervical spine disease. That study was a retrospective analysis
of the Nationwide Inpatient Sample (a sample of hospital discharges). Over a ten-year period, 0.3% of hospital admissions
were for the treatment of cervical spine disease. Complications based on specific disease codes were present in 3.9% of
the patients, with an overall mortality rate of 0.14%. Multivariate analysis identified risk factors for complications, including age (more than seventy-four years), a diagnosis of
myelopathy, a posterior fusion alone, or combined anteriorposterior fusion.
Dysphagia is an under-recognized morbidity after anterior cervical surgery. Using an accepted outcome instrument,
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Lee et al. found that dysphagia was present in >50% of patients at one month and as many as 15% at two years. Risk
factors included female gender, revision procedures, and multilevel procedures. Ischemia of the upper esophageal sphincter mucosa resulting from the use of soft-tissue retractors may
be the cause of postoperative dysphagia. Maintaining the endotracheal balloon pressures at <20 mm Hg, intermittent relaxation of retractors, and cuff reinflation after the retractors
are placed are all strategies that may decrease dysphagia.
Myelopathy
Expansive laminoplasty for decompression in patients with
multilevel spinal cord stenosis and myelopathy generally has
been shown to have an outcome similar to that of anterior
decompression and fusion. Laminoplasty avoids problems
with fusion but has been associated with kyphotic deformity
and chronic neck pain. A number of strategies have been
described to decrease this tendency. Liu et al. preserved the
spinous process-ligament-muscle complex with use of an osteotomy at the base of the spinous process reconstructed with
wire fixation. Thirty patients had a mean increase of 9° of
lordosis, and no patient had increased kyphosis. Other approaches to minimize neck pain include avoiding C7 laminoplasty altogether and performing a laminectomy rather that
a laminoplasty at C3; this affords greater retention of the
musculature attachments to C2. These techniques have been
associated with diminished axial pain in case series. Their acceptance will require better-designed studies to prove their
safety and efficacy.
In the study by Miyata, forty patients who had postoperative ossification of the posterior longitudinal ligament
following a French-door type of laminoplasty were evaluated
with dynamic magnetic resonance imaging. The author found
that the cord had shifted posteriorly and was adequately decompressed. This study again validates that posterior decompression allows posterior cord translation away from the
ventral pathology.
Despite surgical treatment, ossification of the posterior
longitudinal ligament appears to progress in the majority of
patients and can lead to recurrent symptoms. No means to
decrease this tendency have been developed. Furthermore,
it is not known if fusion will likely increase or decrease this
phenomenon.
An important controversy is how to treat and counsel
patients who have cervical stenosis but are asymptomatic.
Recent reports from the Cervical Spine Research Society have
shown that 30% of patients with stenosis experienced minor
trauma and that half of those will deteriorate neurologically.
Future studies should determine if a much more aggressive
surgical approach can prevent neural damage.
Spinal Cord Monitoring
Intraoperative neurophysiologic monitoring during cervical
spine surgery has not been shown to increase patient safety or

to have a positive cost benefit. Smith et al. reviewed 1039 cases
of decompression for non-myelopathy monitored with somatosensory evoked potentials and found a 1% incidence of any
changes. All changes in somatosensory evoked potentials were
corrected by normalizing blood pressure. There was one nondetected cord deficit, and no differences were identified between patients who were monitored and those who were not.
In patients with myelopathy, transcranial motor evoked potentials appear to identify C5 nerve root lesions in a majority
of cases, although they have not been shown to be useful in
preventing injury to this nerve root.
What’s New in Biologic
Topics Related to the Spine
Biologic tools for reconstruction and regeneration continue
to be an important focus of research related to the spine today.
There are continued efforts to enhance the process of achieving spine fusion and to eliminate the need for autogenous iliac
crest bone graft harvest. Since the United States Food and
Drug Administration’s (FDA) post-marketing approval of recombinant human bone morphogenetic protein-2 (rhBMP-2)
in 2002 and the creation of a Humanitarian Device Exemption
for rhBMP-7 late in 2004, the era of recombinant bone morphogenetic proteins for use in spine fusion has continued to
blossom. Given the limited access (with only two companies
producing approved BMPs) as well as their relatively high
cost, there has been renewed interest in promoting less expensive and potentially unvalidated alternative bone-graft
substitutes. Finally, while an increasing amount of research
continues to be focused on understanding the biology of the
intervertebral disc and on developing biologic strategies to retard or reverse degeneration, these treatments still seem to be
quite far from clinical practice.
Recombinant Osteoinductive Proteins
The initial clinical studies on the use of rhBMP-7 (OP-1;
Stryker Biotech, Hopkinton, Massachusetts) for posterolateral spine fusion yielded fusion success rates of 50% to 70%
on radiographs, and these modest fusion rates were attributed
to the use of a “more challenging” noninstrumented spine
fusion model. In 2006, nineteen patients with degenerative
spondylolisthesis were entered into a prospective, randomized, controlled study of instrumented fusion. Patients were
randomized to receive OP-1 putty alone (3.5 mg of OP-1 per
side) or local autograft with hydroxyapatite-tricalcium phosphate granules. The fusions were evaluated with plain radiographs and computed tomographic scans. Sixteen patients
who showed radiographic evidence of fusion underwent instrumentation removal and surgical exploration of the fusion
site. Although seven of the nine patients managed with OP-1
were thought to have fusion on the radiographs, only four of
the seven actually had fusion at the time of exploration, for an
overall OP-1 fusion rate of four of nine. In contrast, nine of
the ten control patients who were managed with local bone
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graft were thought to have fusion on radiographs and seven
of the nine actually had fusion at the time of exploration, for
an overall autograft fusion rate of seven of ten. Although this
difference was not significant because the study was underpowered, the fusion rate of approximately 50% associated
with the use of OP-1 in patients managed with an instrumented fusion is consistent with the numbers reported in
studies of uninstrumented fusion and is still not at a level
equal or superior to that of autograft. It is believed that the
data from the OP-1 posterolateral United States clinical trial
will remain under review by the FDA for consideration for
post-marketing approval.
Although rhBMP-2 (INFUSE; Medtronic Sofamor
Danek, Memphis, Tennessee) has been approved by the
FDA for anterior lumbar interbody fusion, much physiciandirected use has occurred in the posterolateral spine. A subset of data from an investigational device exemption study
involving the use of a higher concentration of rhBMP-2
(20 mg BMP-2 per side) on a compression-resistant matrix
(AMPLIFY; Medtronic) has been published. The report included ninety-eight patients from a prospective, randomized
study in which AMPLIFY was compared with iliac crest bone
graft in patients undergoing a single level instrumented posterolateral lumbar fusion. In this subset of patients, the radiographic fusion rate was 88% for the AMPLIFY group and 73%
for the iliac crest bone graft group (p = 0.05). This was the
first time that a recombinant BMP demonstrated superiority
over autogenous bone graft. With the outcome measures used,
no substantial clinical benefit was detected in association with
the avoidance of harvesting an iliac crest bone graft. Readers
should note that the BMP formulation comprising AMPLIFY
is different (with respect to dose and carrier) than the currently available INFUSE formulation. In another study, the
approved INFUSE kit was used in addition to iliac crest cancellous bone graft for instrumented posterolateral fusion.
The use of INFUSE in combination with iliac crest bone improved the fusion success rate (as determined with thin-slice
computed tomography scans) from 77% with iliac crest graft
alone to 97% with iliac crest graft plus one large InFuse kit
(6 mg BMP-2 per side) wrapped around local bone as a bulking agent. This finding suggests that the current kit, while
likely not sufficient as a stand-alone graft substitute for the
posterolateral spine, can provide a significant enhancer effect,
improving the success of autogenous bone graft.
A primary concern with off-label use of recombinant
BMPs relates to local adverse events. The three most commonly reported local side effects have been heterotopic bone
formation in the surgical approach track, transient bone resorption when used near exposed cancellous bone, and sterile
seroma fluid collections and/or local edema. Most of these
local side effects are believed to be related to the surgeon’s use
of too much BMP either by increasing the concentration of
the growth factor or by overstuffing the defect, which can result in a higher concentration or leakage of BMP into the sur-

rounding tissues. Two reports have described perioperative
swelling in the cervical spine, again most often in association
with excessive BMP doses and with the implant being placed
outside the structural cage or ring. Surgeons who are encountering these local side effects with any regularity should carefully examine their technique to limit the exposure of BMP
directly to cancellous bone (e.g., through less aggressive end
plate decortication) and should avoid the use of excessive
amounts of BMPs in small spaces or overpacking of the BMP
implants.
Other Bone-Graft Substitutes
Although much focus remains on recombinant osteoinductive
proteins, their relatively high cost has continued to encourage
research involving other bone-grafting solutions. A recently
published study demonstrated the failure of platelet concentrates to improve spine fusion healing. This study adds to a
growing body of literature suggesting that platelet gels either
inhibit or have no effect on spine fusion healing. In addition,
an animal study confirmed that platelet-derived growth factor,
transforming growth factor-beta, and platelet gel inhibited the
BMP activity in demineralized bone when implanted together
in animals. While platelet gels may serve a purpose for impaired wound-healing, their role in promoting bone formation remains in question.
A recently published animal study investigated the role
of simvastatin in achieving posterolateral spine fusion in rabbits. Statins have been shown to increase the expression of
BMPs and may enhance bone formation in certain situations.
In this study, the systemic administration of simvastatin did not
positively or negatively affect spine fusion. It is possible that
local administration of statins may have more profound effects.
Interest in mesenchymal stem cells has increased with
the introduction of two mineralized allograft products that
are claimed to have cryopreserved stem cells. These products
are claimed to immunodeplete the non-stem cells from allograft and to provide a mineralized scaffold with allogeneic
stem cells. Since these products are regulated as “minimally
manipulated tissues,” little outcome data are available. The
studies that are under way may not include the proper controls to assess whether the stem cells are providing any increased healing in comparison with the allograft alone. These,
as well as other, minimally manipulated products that are
claimed to have bone-healing potential must be carefully
evaluated by surgeons because the FDA does not require definitive proof of bone-enhancing capability. In general, the
number of stem cells present in bone marrow is relatively
small, and without specific signals (e.g., BMP) it is not clear
whether sufficient numbers of cells are present to initiate bone
formation de novo.
Biologic Treatments for Disc Degeneration
Progress toward biologic treatments to prevent or retard disc
degeneration continued at a slow pace. Continued evidence of
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beneficial effects of recombinant BMPs (BMP-7, BMP-2,
growth differentiation factor-5) on disc metabolism in animals has prompted the planning of a clinical trial to investigate the response in humans. A majority of this preclinical
work has been performed with OP-1, which can prevent disc
height loss after needle puncture injury and can restore disc
height that has been already lost after anular puncture in rabbits. Although this technology is a long way from clinical use,
it is worth monitoring developments in this area, which could
ultimately provide a groundbreaking technology for the treatment and prevention of many degenerative spine disorders.
What’s New in Spinal
Deformity Surgery
Over the past year, many articles and presentations addressed
the etiology of adolescent idiopathic scoliosis and the treatment of early-onset scoliosis as well as congenital spinal deformity, particularly thoracic insufficiency syndrome. There also
have been advances in the treatment of kyphosis, neuromuscular scoliosis, and spondylolisthesis. The Scoliosis Research
Society (SRS) continues to be very interested in investigating
complications of surgical treatment.
Etiology of Adolescent Idiopathic Scoliosis
Investigators from two centers presented papers at the recent
SRS meeting that further emphasized the potential genetic
markers and familial characteristics of idiopathic scoliosis.
Identification of the etiology of idiopathic scoliosis remains
the number-one research goal of the SRS.
Early-Onset Scoliosis
Several new methods are evolving to allow for continued
growth with intermittent surgical lengthening of the spine for
patients with infantile and juvenile scoliosis. Such techniques
utilize bilateral instrumentation, intermittent distraction, and
multiple fixation points at the top and bottom and potentially
at the apex of the deformity.
Congenital Spinal Deformity
The “titanium rib” technique with expansion thoracostomy
has continued to gain popularity and momentum. Early data
continue to suggest that distraction techniques associated
with chest wall surgery can slowly lengthen the spine without creating a major neurologic deficit and with modest improvement in chest volumes. Documentation of changes in
pulmonary function in these patients is not straightforward,
however. One study, conducted at The Children’s Hospital
of Philadelphia, did not demonstrate a significant improvement in lung function after expansion thoracostomy surgery.
According to one multicenter study presented at the SRS
meeting, patients with thoracic insufficiency syndrome
clearly had marked reduction in their quality of life when
compared with other children on the basis of the Child
Health Questionnaire.

Kyphosis
One excellent paper that was presented at the SRS annual
meeting emphasized the risk of increased kyphosis and pain
following implant removal because of idiopathic scoliosis.
Previous presentations have emphasized the problems associated with implant removal in the adult population. It appears
that this is a substantial concern in the teenage population as
well. The extent to which changes in the deformity reflected
bending of the fusion mass as opposed to motion at undetected pseudarthroses was not entirely clear.
Neuromuscular Scoliosis
Assessment of the benefits of surgical treatment for patients
with cerebral palsy and spinal deformity is quite complex.
Most previous studies have only assessed radiographic parameters as opposed to a patient/parent evaluation. One paper
that was presented at the SRS meeting focused on eighty-one
children with cerebral palsy (and their families) who were
undergoing spinal fusion. The postoperative complication
rate was high (33%). However, the family satisfaction rate
was quite high (92%). Eighty-seven percent reported improvement in sitting balance, and 66% believed that quality
of life had improved. Unfortunately, at this time, healthrelated quality-of-life measures for this population of patients are not standardized and validated.
Spondylolisthesis
Classification of spondylolisthesis has remained elusive. Authors from Boston, Montreal, and France, as part of a multicenter study, have identified two distinct groups regarding the
sagittal alignment of patients with high-grade spondylolisthesis. Critical factors appear to be the orientation of the pelvis
and the sacrum, the obliquity of the L5-S1 disc, and the degree
of dysplasia of the L5 element.
Adolescent Spinal Deformity
There continues to be a substantial effort to investigate the
results associated with the use of pedicle screw implants, particularly in the thoracic spine, for the treatment of adolescent
idiopathic scoliosis. Most data suggest that correction is somewhat better in association with this technique than in association with techniques involving the use of either hooks or wires
or a combination of hooks, wires, and screws. It appears that
Cobb angle correction, translational correction, and rotational correction are all slightly better with pedicle screws than
with other implants. Furthermore, for curves of between 70°
and 100°, it appears that anterior and thoracoscopic releases
frequently are not required if pedicle screw implants are used
to achieve fixation at all levels. In terms of cost analysis, pedicle screw implants are expensive, but if they obviate the need
for open or thoracoscopic anterior releases, this is offset by the
shorter operating time, decreased surgical morbidity, and
fewer days spent in the hospital and the intensive care unit
than is the case with a combined approach. One potential dis-
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advantage of the pedicle screw technique is that the hypokyphotic thoracic spine remains hypokyphotic postoperatively
as most of the pedicle screw derotational techniques being
employed now push anteriorly on the posterior convex spine.
Furthermore, there is no clear evidence that the increased correction achieved with pedicle screw implants translates to
higher Health Related Quality of Life scores on SRS surveys.
Adult Spinal Deformity
An SRS classification system for adult spinal deformity continues to evolve. This work is being accomplished by the Adult
Spinal Deformity Committee of the SRS, led by Thomas Lowe,
MD. The aspects of the classification include curve type,
sagittl modifiers, distal lumbar degenerative modifiers, and
global balance parameters. In addition, Frank Schwab, MD,
has a very similar classification scheme, which is reflective of
the likelihood of surgical intervention. Factors that predict
the need for surgical treatment of adult scoliosis include sagittal and coronal plane decompensation, substantial rotatory
subluxations, spinal stenosis symptoms, and deformity progression. The coronal Cobb angle itself is not a primary
determinant for surgical intervention. It does appear the
SRS Health Related Quality of Life instrument is far more
responsive to change following the surgical treatment of adult
spinal deformity than it is following the surgical treatment of
adolescent deformity. With adolescent deformity, it appears
that the only domain that substantially changes after surgery is
the self-image domain, whereas with adult spinal deformity,
changes typically are identified in all domains.
Complications after surgery for the correction of spinal
deformity are more common in adults than in adolescents.
These complications include pseudarthrosis, proximal and
distal junctional kyphosis, and an extended recovery. RhBMP
is being considered as an alternative or adjunct to reduce the
pseudarthrosis rate in adults with spinal deformity. However,
use of these products for posterior surgery constitutes an offlabel use and is prohibitively expensive for many centers.
Complications
The Morbidity and Mortality Committee report to the membership at the annual SRS meeting was an exhaustive study of
the complications of spinal fusion for the treatment of adult
scoliosis. Adult patients who had idiopathic scoliosis were compared with those who had scoliosis of a purely degenerative origin. From 2003 to 2005, 2852 patients underwent spinal fusion
for the treatment of adult scoliosis. The complication rate was
significantly higher in the degenerative group than in the idiopathic group (15.6% compared with 12.3%; p < 0.01). The
death rate was the same in both groups. The neurologic complication rate was 1.3% overall, with six documented spinal cord
deficits (0.21%), but only one deficit was complete (0.04%).
What’s New in Spinal Cord Injury
Research in the area of spinal cord injury is making strides in

understanding the mechanisms of secondary injury and the factors inhibiting axonal regeneration. Cell death not only occurs
at the time of injury but also is due to a cascade of secondary
events that result in further neurologic dysfunction. Multiple
biochemical processes, including the production of reactive oxygen species, excitotoxicity from neurotransmitter release, and
imbalances in ion concentrations at a cellular level, culminate in
the death of neurons and supporting glial cells.
Spinal cord injury is followed by changes that inhibit the
regrowth of axons and the reestablishment of neural connections. It was once thought that axonal regeneration could not
occur within the central nervous system, but it is now understood that central nervous system axons can regenerate in the
proper environment. Formation of a glial scar and production
of inhibitory compounds in the extracellular matrix impede
the regrowth of axons across the site of injury.
As a result of a better understanding of the multiple biochemical processes that result in secondary cell injury and the
inhibition of axonal regeneration, many new therapies are being studied. In addition, new strategies are being investigated
to bridge the gap across a damaged spinal cord segment.
Therapies to Reduce Secondary Injury
Historically, the investigation of spinal cord injury therapies
has focused on the inhibition of lipid peroxidation and the
use of anti-inflammatory drugs, but through a better understanding of the mechanisms leading to secondary injury, new
investigational agents have targeted multiple areas of the biochemical cascades that lead to cell death. Calpain and caspase
proteases are both upregulated and associated with secondary
injury cascades in spinal cord injury. Recent studies on 6shogaol, an apoptotic inhibitor, have shown significant improvements in hind-limb function in rodent models. Erythropoietin (EPO) and derivatives of this compound exert an
anti-apoptotic effect in the setting of hypoxia and have been
shown to improve cell survival after ischemic brain injury
and spinal cord injury in rodent models. Polyethylene glycol
(PEG), which is thought to interact with and stabilize injured cell membranes, has been shown to have neuroprotective properties in spinal cord injury models. Minocycline has
been shown to have potent anti-inflammatory and neuroprotective properties after spinal cord injury and is currently being investigated in a preliminary clinical trial in
Canada. Growth factors also have been studied extensively
as a means to reduce secondary injury and also to improve
nerve regeneration. Growth factors administered directly at
the site of experimental spinal cord injury or via gene therapies have been shown to reduce cell death and to improve axonal regeneration.
Therapies to Promote Axonal Regeneration
Two therapies to promote axonal regeneration have been
evaluated in clinical trials over the last three years, and a
number of other potential therapies are being evaluated
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in laboratory studies. Rho, a small signaling protein, has
been shown to result in the inhibition of axonal regeneration
after experimental spinal cord injury. C3 transferase (C3),
an inhibitor of Rho, was shown to have neuroprotective
and regenerative properties in animal models. Cethrin (BioAxone Therapeutic, Saint-Laurent, Quebec), a combination
of C3 with a transport sequence that helps the protein to
cross cell membranes, showed encouraging results in a recent Phase-I/IIa multicenter clinical trial. The application
of Cethrin in the epidural space at the time of decompressive
or stabilization surgery in thirty-seven patients with American Spinal Injury Association (ASIA) type-A injuries resulted in improvement of at least one ASIA grade in 30% of
the patients within six weeks. Historically, <5% of patients
with an ASIA type-A lesion will have any improvement.
Obviously, that study was small, but it warrants further
clinical studies.
Although much research has been focused on reducing
the immune response to spinal cord injury, other approaches
have involved the utilization of immune cells (macrophages)
to facilitate axonal regeneration. Animal testing with genetically modified autologous macrophages showed encouraging
results in rodent models and prompted human clinical studies. ProCord (Proneuron Biotechnologies, Los Angeles,
California) therapy, involving the injection of “activated”
autologous macrophages into the contused area of a spinal
cord injury, was begun as a Phase-II clinical study in the
United States and Israel. The trial, which enrolled twenty-four
patients, was suspended from further patient recruitment because of funding issues, but the patients who were managed
are still being followed.
Other investigations have targeted neurite growth inhibitory protein, Nogo-A, which is a cell surface protein, expressed after spinal cord injury, that inhibits neurite growth.
Antibodies to Nogo-A have been administered intrathecally in
rodent spinal cord injury models, with increasing axonal regeneration and improved neurologic recovery being noted.
Rolipram, a specific inhibitor of phosphodiesterase 4, has also
been shown to improve axonal regeneration after spinal cord
injury in rodent models.
Cell-based therapies involving Schwann cells, olfactory
ensheathing cells, and stem cells as well as other forms of
implantable scaffolding have been shown to facilitate axonal
regeneration and remyelination after spinal cord injury in
animal models. Lima et al. recently reported on the implantation of olfactory mucosa at the site of injury in seven patients with an acute complete spinal cord injury and noted
an improvement in the ASIA grade in all patients, with two
patients having two grades of improvement. Implantation
of stem cells has received substantial attention in the media
as a potential cure for spinal cord injury. However, as encouraging as the results in animal studies have been, human
clinical trials have not proven that these therapies are currently effective.

What’s New in the Treatment
of the Lumbar Spine
Novel treatments and advances in the treatment of lumbar
degenerative disorders continue to be of high interest to clinicians and researchers as these pathologies represent some of
the more common musculoskeletal disorders. The development of novel technologies is very exciting, but we certainly
need appropriate evidence of their efficacy.
Motion Preservation/Lumbar Disc Arthroplasty
The area of motion preservation of the lumbar spine—specifically, disc arthroplasty—continues to be a topic of high interest, and several studies have evaluated the efficacy of the
treatments. Zigler et al., in a presentation of the slightly
longer-term follow-up of their prospective randomized study
of one prosthesis, compared the results of arthroplasty with
those of fusion. The minimum duration of follow-up was two
years, with some patients being followed for as long as three
years. These early results showed that disc arthroplasty was as
good as fusion, with some early differences favoring disc arthroplasty in terms of the pain score and patient satisfaction
disappearing by the third year.
One group of investigators presented a systematic literature review on the efficacy and safety of intervertebral disc
prostheses for the lumbar spine. This meta-analysis primarily
examined two of the FDA-approved disc devices in comparison with fusion. The conclusions were that the scientific evidence presently available for these devices was not sufficient to
recommend the use of either one for the treatment of lumbar
disc pain in routine clinical practice. The authors recommended additional studies with larger numbers of patients.
Adjacent Segment Degeneration
Theoretically, the greatest benefit of motion preservation over
fusion would be a decrease in or the avoidance of adjacentsegment disease. However, the delineation of the prevalence
of adjacent-segment disease is critically important. In one
prospective study of eighty patients undergoing an anterior
interbody fusion at L5-S1, the two proximal adjacent levels
were monitored for an average duration of follow-up of five
years. The rate of advanced degeneration at either of these levels was not significantly changed from the initial preoperative
rate. The authors concluded that adjacent-segment disease after anterior interbody fusion is not a clinical problem.
Two studies have examined the fate of the L5-S1 level
following spine fusion to L5. One study evaluated nineteen
patients with fusion to L5 and showed that 32% of the patients required revision of the fusion to the sacrum at the
time of the five-year follow-up, and the investigators predicted a 60% survival rate at ten years of follow-up. Another
center presented a study of thirty patients after five years of
follow-up. The investigators noted a high rate (68%) of progressive degeneration at the L5-S1 level and noted a 20% rate
of revision to the sacrum.
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Biological Promoters of Fusion
In addition to the review of biologics earlier in this update,
three studies are particularly pertinent to the lumbar spine
and will be discussed here. Dimar et al. reported the results
of a prospective randomized study of 463 patients in which
the use of rhBMP-2 was compared with autogenous bone
graft for posterolateral lumbar fusion. The authors reported
significant differences between the groups in terms of operative time and blood loss but not in terms of the length of hospital stay. The fusion rates were similar in the two groups, but
the rate of nonunion failure was higher in the autograft group
than in the rhBMP-2 group.
Vaccaro et al. presented their results after the use of
rhBMP-7 for uninstrumented posterolateral spinal fusion.
Twenty-six patients were followed to the five-year timepoint, and the five-year results were compared with the
earlier (two-year) results presented for a larger group. The
authors reported that the fusion rates and clinical outcomes
were maintained at the longer-term follow-up.
Angevine et al. studied the cost-effectiveness of the use
of rhBMP-2 for the primary surgical treatment of adult scoliosis. This retrospective cohort cost-offset analysis examined the
charges for each hospitalization at one institution for all adults
undergoing this procedure. The investigators found that the
use of rhBMP-2 increased the cost of the index procedure for
adult idiopathic scoliosis, but was cost-neutral when controlling for the type of surgery, the number of levels, and the
number of pedicle screws used. Furthermore, when taking
into account the differential rate of pseudarthrosis and the
associated costs, the use of rhBMP-2 was more cost-effective.
Nonoperative Care
Perhaps the most interesting and promising developments
were related to the nonoperative treatment of lumbar spine
abnormalities. One group of investigators presented the results of a prospective, randomized study of seventy-four patients with lumbosacral radiculopathy who were managed
with oral administration of tumor necrosis factor-alpha
(TNF-alpha) antagonists or placebo. Compared with placebo,
the TNF-alpha antagonist showed a reduction in maximum
daily leg pain over the first two weeks, but by three weeks there
were no differences. Additional, longer-term study is needed
to fully delineate the benefits of this approach.
One group reported on a prospective series of 346 patients receiving nerve root injections for the treatment of a
variety of degenerative lumbar disorders. The investigators
demonstrated efficacy and the avoidance of surgery in a large
percentage of patients (in increasing order of efficacy) who
had moderate disc herniations, degenerative spondylolisthesis, spinal stenosis, isthmic spondylolisthesis, foraminal
stenosis, degenerative scoliosis, and failed back syndrome.
Poor outcomes were found in association with stenosis, extraforaminal disc herniations, recurrent disc herniations,
and failed back surgery when combined with instability.

Complications
Wound complications are always of concern. The identification of possible risk factors for prevention was the topic of
one study of 18,352 patients, which examined risk factors for
wound dehiscence and deep and superficial infections. Significant risk factors for wound complications, in order of
increasing risk, included smoking, non-insulin-dependent
diabetes mellitus, and insulin-dependent diabetes. The combination of smoking and diabetic status further increased the
risk, and great care should be exercised when treating these
patients.
Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculoskeletal system that received a Level of Evidence grade of I. Over
100 medical journals were reviewed to identify these articles,
which all have high-quality study design. In addition to articles published previously in this journal or cited already in this
Update, sixteen level-I articles were identified that were relevant to spine surgery. A list of those titles is appended to this
review after the standard bibliography. We have provided a
brief commentary about each of the articles to help guide your
further reading, in an evidence-based fashion, in this subspecialty area.
Upcoming Meetings and Events
Related to Spine Surgery
The forty-second annual meeting of the Scoliosis Research
Society (SRS) will be held on September 5 through 8, 2007,
at the Edinburgh International Conference Center, Edinburgh, Scotland. It will be preceded by a one-day course entitled “Update on Congenital Spinal Deformity,” to be held on
September 4, 2007. Web site: www.srs.org
The twenty-second annual meeting of the North American Spine Society (NASS) will be held on October 23 through
27, 2007, at the Austin Convention Center in Austin, Texas. It
will be preceded by several precourses and two half-day meetings of the Biologics Research Section and the Motion Preservation Section, which are being developed by the society. Web
site: www.spine.org
The thirty-fifth annual meeting of the Cervical Spine
Research Society (CSRS) will be held on November 29
through December 1, 2007, at the Palace Hotel in San Francisco, California. It will be preceded by an Instructional
Course sponsored by the Society on November 28, 2007.
Web site: www.csrs.org
The Federation of Spine Associations will present the
spine program at Specialty Day at the annual meeting of the
American Academy of Orthopaedic Surgeons (AAOS), to be
held on Saturday, March 8, 2008, in San Francisco, California.
Web site: www.aaos.org
The annual meeting of the International Society for
the Study of the Lumbar Spine (ISSLS) will be held May
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25 though 31, 2008, in Geneva, Switzerland. Web site:
www.issls.org
The thirty-fourth annual meeting of the American
Spinal Injury Association (ASIA) will be held on June 19
through 22, 2008, at Loews Coronado Bay Resort in San
Diego, California. Web site: www.asia-spinalinjury.org
The fifteenth annual International Meeting on Advanced Spinal Techniques (IMAST) will be held on July 8
through 11, 2008, at the Hong Kong Convention Center in
Hong Kong, China. Web site: www.imastonline.com
NOTE: The authors thank Drs. Jim Harrop, Alan Hilibrand, Steve Mardjetko, Dan Riew, and
Harvinder Sandhu for peer reviewing the sections of this manuscript.
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Evidence-Based Articles Related to Spine Surgery
Brox JI, Reikerås O, Nygaard Ø, Sørensen R, Indahl A, Holm I, Keller A,
Ingebrigtsen T, Grundnes O, Lange JE, Friis A. Lumbar instrumented fusion
compared with cognitive intervention and exercises in patients with chronic
back pain after previous surgery for disc herniation: a prospective randomized controlled study. Pain. 2006;122:145-55.
In this study from Norway, spinal fusion was compared with a cognitive intervention and exercise program following the “failure” of a previous
disc herniation operation to relieve back pain. There was a 50% success rate in
the fusion group and a 48% success rate in the cognitive intervention/exercise
group. Depending on one’s perspective, either both modalities were equally effective or equally ineffective in this very difficult group of patients. This study
suggests there is no “one answer” to the patient who has continued chronic
low-back pain after previous surgery for the treatment of a disc herniation.
Clarke J, van Tulder M, Blomberg S, de Vet H, van der Heijden G, Bronfort G.
Traction for low back pain with or without sciatica: an updated systematic
review within the framework of the Cochrane collaboration. Spine. 2006;
31:1591-9.
This study was a review of the literature on traction. There was not
sufficient evidence to recommend traction for patients with low-back pain or
sciatica. Because most studies were underpowered, the literature does not allow a negative conclusion that traction is not effective.
Clarke JA, van Tulder MW, Blomberg SE, de Vet HC, van der Heijden GJ,
Bronfort G. Traction for low-back pain with or without sciatica. Cochrane
Database Syst Rev. 2005;(4):CD003010.
This paper identified twenty-four randomized clinical trials involving
>2000 patients. Five of the trials were considered “high quality.” The authors
concluded that there was conflicting evidence regarding the short-term effectiveness of either continuous or intermittent traction as compared with placebo, sham treatment, or other treatments when managing patients who have
either chronic low-back pain or a mixture of low-back pain and sciatica. This
finding suggests that there is nothing “magical” about employing traction
when physical therapy is being used to treat low-back pain.
de Graaf I, Prak A, Bierma-Zeinstra S, Thomas S, Peul W, Koes B. Diagnosis
of lumbar spinal stenosis: a systematic review of the accuracy of diagnostic
tests. Spine. 2006;31:1168-76.
This was a review of the literature for published articles examining diagnostic studies for spinal stenosis. The authors found twenty-four articles (fifteen
on imaging tests, seven on clinical tests, and two on other diagnostic studies).
The authors found that the published studies were of poor quality and were not
directly comparable, and they concluded that no firm conclusions could be
made regarding the different tests. The results of this study are not surprising as
spinal stenosis is a clinical syndrome with a large number of varying symptoms
that may all not be present in any particular patient. The diagnosis of spinal
stenosis is determined by the clinician on the basis of a combination of the test
results, the clinical information and history, and the imaging studies.
Finckh A, Zufferey P, Schurch MA, Balagué F, Waldburger M, So AK. Shortterm efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica.
A randomized controlled trial. Spine. 2006;31:377-81.
The authors performed a randomized controlled trial evaluating the
use of a single intravenous bolus of methylprednisolone (500 mg) for the
treatment of acute sciatica (duration of symptoms, less than six weeks). The
authors noted a significant decrease in sciatic pain in association with the intravenous administration of methylprednisolone over the first twenty-four
hours but noted that the effects were transient and of small magnitude. This
study demonstrates that a high-dose intravenous bolus of steroids may provide some short-term pain relief and, thus, may allow patients to better participate in physical therapy and other conservative modalities to relieve the
symptoms of sciatica.

Freeman BJ, Fraser RD, Cain CM, Hall DJ, Chapple DC. A randomized,
double-blind, controlled trial: intradiscal electrothermal therapy versus
placebo for the treatment of chronic discogenic low back pain. Spine.
2005;30:2369-78.
This was a randomized controlled study comparing intradiscal electrothermal therapy (IDET) with sham treatment for patients with chronic low
back pain. Thirty-eight patients were randomized to IDET, and nineteen were
randomized to sham treatment. All patients had one or two-level degenerative
low-back pain confirmed with magnetic resonance imaging and discography.
At six months, no improvement from baseline was observed in either group,
and no differences were present between the IDET and sham groups. This was
a well-done study that contradicted a previous randomized controlled study
that had demonstrated a slight to moderate effect of IDET as compared with
sham treatment. Taking these studies together, IDET appears to have little
clinical efficacy.
Gibson JN, Waddell G. Surgery for degenerative lumbar spondylosis: updated
Cochrane Review. Spine. 2005;30:2312-20.
The authors performed an extensive review of the literature on the
surgical treatment of degenerative lumbar spondylosis and concluded that
there is a paucity of good studies on this topic. There is limited evidence to
support some aspects of surgical practice. The authors underscored the importance of critical appraisal of the literature when formulating individual
practice behaviors.
Kääpä EH, Frantsi K, Sarna S, Malmivaara A. Multidisciplinary group rehabilitation versus individual physiotherapy for chronic nonspecific low back
pain: a randomized trial. Spine. 2006;31:371-6.
This was a prospective randomized trial, from two different centers,
that included 120 women who were employed as health-care and social-care
professionals and had low-back pain. The women were randomized to either a
multidisciplinary group rehabilitation program for seventy hours or individual therapy for ten hours. The authors found no differences between the two
groups at the time of the two-year follow-up, with both groups demonstrating
favorable effects from the therapy that held up at the time of the final followup. The study shows that group therapy that is comprehensive is as effective as
individual therapy and that both demonstrate positive effects at the time of
two-year follow-up.
Khadilkar A, Milne S, Brosseau L, Wells G, Tugwell P, Robinson V, Shea B,
Saginur M. Transcutaneous electrical nerve stimulation for the treatment of
chronic low back pain: a systematic review. Spine. 2005;30:2657-66.
The authors set out to perform a meta-analysis of the literature on
transcutaneous electrical nerve stimulation (TENS) for the treatment of lowback pain but only found two studies that met criteria to include in this analysis. They concluded that evidence to support the use of TENS treatment for
low-back pain is limited.
Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Järvinen
S, Niinimäki J, Veeger N, Seitsalo S, Hurri H. The treatment of disc herniation-induced sciatica with Infliximab: results of a randomized, controlled, 3month follow-up study. Spine. 2005;30:2724-8.
This was a prospective randomized controlled study of forty patients
with sciatica due to a lumbar disc herniation. Patients were managed with either a single infusion of the medication (antibody against TNF-alpha) or placebo. Both groups showed a significant reduction in leg pain, without any
significant differences between the two groups. The authors concluded that
there was no support for the use of this medication for lumbar disc herniation-induced sciatica. With the recent interest in TNF-alpha blockers for the
treatment of sciatic pain, this study demonstrates that there was no difference
between the medication and the placebo, which may reflect the positive natural history of the disorder itself.
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Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin
M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet.
2005;366:643-8.
Patients with isolated epidural spinal metastases were randomized to
radiation therapy or surgical decompression followed by postoperative irradiation. The primary end point was the ability to walk. The study was discontinued before full enrollment because the surgical group had significantly better
results, including the percentage of patients who remained able to walk, the
duration of walking, the number of patients who regained the ability to walk,
and a decreased need for corticosteroids and opioids.
This convincing study demonstrates that for patients with isolated
epidural spinal cord compression, surgery followed by radiation therapy is
associated with a better outcome than radiation alone. This was true for patients with significant neurologic deficits and for those who were neurologically intact.
Rosenfeld M, Seferiadis A, Gunnarsson R. Active involvement and intervention in patients exposed to whiplash trauma in automobile crashes reduces
costs: a randomized, controlled clinical trial and health economic evaluation.
Spine. 2006;31:1799-1804.
This randomized study demonstrated that for patients exposed to
whiplash trauma in a motor-vehicle collision, active involvement and intervention were both less costly and more effective than a standard intervention.
There was reduced pain and less sick leave in the active involvement group.
Sherman KJ, Cherkin DC, Erro J, Miglioretti DL, Deyo RA. Comparing yoga,
exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med. 2005;143:849-56.
In this randomized controlled study of patients with prior episodic
low-back pain, Viniyoga was compared with group exercise taught by a physical therapist or through an instructional booklet. Viniyoga is a safe technique
that emphasizes breathing and posture for the treatment of low-back pain
symptoms. At twenty-six weeks of follow-up, there was significant improvement in both the exercise and yoga groups. The yoga group had superior outcomes, but the differences were not significant compared with the exercise
group. Both therapeutic groups had significantly better results than did the
subjects who used the booklet. The conclusions of the study are limited in that
the results cannot be generalized because the treatment population was
poorly defined. Furthermore, instructions were given in each group by one
practitioner who may have biased the outcome. The duration of follow-up
was short, and it is unknown if the observed effect will be lasting. Finally,
compliance with the program was not reported.

Singh K, Samartzis D, Strom J, Manning D, Campbell-Hupp M, Wetzel FT,
Gupta P, Phillips FM. A prospective, randomized, double-blind study evaluating the efficacy of postoperative continuous local anesthetic infusion at the
iliac crest bone graft site after spinal arthrodesis. Spine. 2005;30:2477-83.
Continuous infusion of local anesthetic has been developed to decrease postoperative pain and is used in many surgical disciplines. This study
tested its efficacy in patients undergoing spinal fusion with use of iliac crest
bone grafts. Thirty-seven patients were randomized to placebo (saline solution infusion) or Marcaine (90 mL of 0.5%) with use of a continuous infusion
technique. Significantly lower pain scores and less opioid consumption was
present in the anesthetic group. No complications occurred in either group.
The pump and anesthetics were cost-neutral. This was a well-done study
showing the efficacy of an inexpensive (cost-neutral) method in decreasing
postoperative pain. The use of this anesthetic technique should be considered
in other musculoskeletal surgical areas.
Steele EJ, Dawson AP, Hiller JE. School-based interventions for spinal pain: a
systematic review. Spine. 2006;31:226-33.
This was a systematic literature review of twelve papers. All twelve papers received a “weak quality rating”; therefore, no conclusions could be made
regarding the effectiveness of a school-based spinal health intervention program. This paper strongly suggests there is no clear evidence that schools and
health-promotion programs help with the treatment of spinal pain. There is
simply not a clear answer in the current peer-review literature.
Yukawa Y, Kato F, Ito K, Terashima T, Horie Y. A prospective randomized study
of preemptive analgesia for postoperative pain in the patients undergoing posterior lumbar interbody fusion: continuous subcutaneous morphine, continuous
epidural morphine, and diclofenac sodium. Spine. 2005;30:2357-61.
The authors studied the use of preoperative and postoperative continuous subcutaneous morphine, continuous epidural morphine, and diclofenac sodium in a prospective randomized fashion. The diclofenac
treatment group had the lowest initial visual analog scale pain scores immediately after surgery (p = 0.059) but required more supplemental analgesic
medications in the first seventy-two hours after surgery (p = 0.013). The epidural group had more side effects, most commonly nausea and vomiting,
than the other groups (p = 0.015). This study is very relevant to the practice
of spine surgery as effective postoperative analgesia improves patient outcomes, reduces secondary complications by allowing for early mobilization,
and shortens hospital stay. On the basis of the results of this study, it appears
that the administration of continuous subcutaneous morphine might be a
safe and useful approach for the treatment of postoperative pain after spinal
surgery and warrants further study.

